$SLQT

SelectQuote (SLQT) Projected to Post Quarterly Earnings on Thursday

SelectQuote (SLQT) is projected to announce its Q2 2026 earnings before market open on Thursday, February 5th. Analysts anticipate earnings of $0.17 per share and revenue of $530.7260 million for the quarter. The company's stock currently trades at $1.49, with institutional investors holding 34.59% of shares, and analysts currently have a consensus "Hold" rating with a target price of $3.88.

Original reporting
MarketBeat · MarketBeat
Published Jan 29, 2026, 8:08 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jan 29, 2026, 9:00 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
SelectQuote (SLQT) Projected to Post Quarterly Earnings on Thursday — source image
Decision brief

The 30-second read

$SLQTNeutralMed
01

Why it matters

Earnings results may affect investor sentiment and stock valuation, especially if they deviate from analyst estimates.

02

Market read

While the company's earnings are significant for current investors and sector watchers, the overall market impact remains limited due to the company's size and sector.

03

What to watch

Potential impact of macroeconomic conditions and sector-specific regulatory changes that could influence earnings and stock performance.

Timing: high

Background

SelectQuote is a provider of insurance comparison and enrollment services, with earnings influenced by insurance industry trends and consumer demand.

Company-level read

Ticker impact

$SLQTNeutralMedium confidence
Context

The upcoming earnings report is a significant event for SelectQuote, potentially influencing its stock price.

Expected impact

Potential moderate upward movement if earnings meet expectations; downside risk if results fall short.

Evidence & confidence

Earnings are projected to be in line with analyst estimates, but the stock's low current price and analyst target suggest room for appreciation. However, the market's reaction will depend on the actual results and guidance.

$SLQTNeutralLow confidence
Context

The stock's low relevance score (0.103277) indicates minimal immediate impact on broader markets, but notable for traders with a focus on this specific ticker.

Expected impact

Limited impact; expect potential short-term price fluctuations around earnings date.

Evidence & confidence

The low relevance score suggests limited market attention, so the impact is expected to be confined to short-term trading activity.

Market effects

The earnings could influence sentiment in the financial services and insurance sectors, especially if results differ from expectations.

Limited regional impact; company primarily operates domestically.

Minimal global market relevance due to company size and sector.

Counterpoint

If earnings significantly surpass expectations, the stock could rally towards the analyst target of $3.88, representing over 160% upside from current levels.

Key entities

  • SelectQuote

    A provider of insurance comparison and enrollment services.

Related articles

$SLQTHighAI 8/10

Why is Selectquote stock sliding today?

Selectquote (SLQT) shares dropped 16.59% in pre-market trading to $0.643 after missing Q4 2026 earnings and revenue estimates. The company reported a loss of $0.19 per share and $321.7M in revenue, while FY2027 guidance of $1.35B-$1.45B fell below consensus. Analysts had already lowered ratings due to sector headwinds, including Medicare Advantage marketing cuts and reimbursement pressures.

$RBAHigh

Why This U.S. Auto Retail Stock is Barclays’ Top Pick Right Now

Barclays named RB Global Inc (RBA) its top U.S. auto retail pick, citing an attractive valuation at 12.7x EV/EBITDA, market share gains, and cyclical improvements in its Heavy Equipment & Transportation segment. RBA reported Q2 2026 revenue of $1.32B, beating estimates, with 11% gross transaction value growth. Barclays expects RBA to gain market share from Copart Inc (CPRT) in the salvage vehicle auction market.

$GHHighAI 8/10

Guardant ordered to pay $245m in DNA sequencing patent dispute

Guardant Health was ordered to pay $245.2m to TwinStrand Biosciences and the University of Washington for patent infringement. The ruling covers 11 products, including Guardant360 CDx, and includes damages, royalties, and interest. Guardant plans to appeal, while TwinStrand affirms its commitment to its intellectual property.

$KURAMed

Why is Kura Oncology stock surging today?

Kura Oncology's stock rose 11.6% in pre-market trading after CEO Troy Wilson bought 100,000 shares for $1.24 million, his second large purchase in a week. Analysts Citigroup and Jefferies reaffirmed positive ratings, citing strong commercial momentum for KOMZIFTI and Q2 earnings beat. The stock surpassed its 52-week high of $12.90.

$BEMed

Nancy Pelosi Made Millions On Nvidia Options. Now She’s Betting $3 Million On 1 AI Energy Stock

Paul Pelosi, spouse of House Speaker Nancy Pelosi, acquired 15,000 shares and 200 call options of Bloom Energy (BE) in July 2026, with a potential investment ranging from $3 million to $12 million. Bloom Energy reported Q2 2026 revenue of $1.065 billion, up 165.5% year-over-year, and raised full-year guidance to $3.9 billion to $4.2 billion. The stock closed at $204.02 on August 24, 2026, up 134.8% year-to-date. The Pelosi household also added to an existing Intel (INTC) position.